Keyphrases
Patient Selection
100%
Active Surveillance
100%
Patients with Prostate Cancer
100%
Low-risk Disease
40%
Prostate Cancer
20%
Patient Management
20%
Risk Stratification
20%
Prostate-specific Antigen
20%
Imaging Technology
20%
Prostate Cancer Screening
20%
Prostate Cancer Risk
20%
Early Identification
20%
Overtreatment
20%
Low Risk
20%
Multiparametric MRI (mpMRI)
20%
Program Use
20%
Clinically Significant Prostate Cancer
20%
Urinary Biomarkers
20%
Tissue Biomarkers
20%
Improved Detection
20%
Early Management
20%
Clinically Insignificant
20%
Risk Selection
20%
Epstein Criteria
20%
Modified Criteria
20%
Accurate Selection
20%
Immunology and Microbiology
Magnetic Resonance Imaging
100%
Prostate
100%
Cancer Mortality
100%
Prostate Specific Antigen
100%
Medicine and Dentistry
Prostate Cancer
100%
Diseases
75%
Magnetic Resonance Imaging
25%
Biological Marker
25%
Prostate Specific Antigen
25%
Cancer Mortality
25%
Biopsy Technique
25%
Risk Stratification
25%
Prostate Cancer Diagnosis
25%
Overdiagnosis
25%
Nursing and Health Professions
Prostate Cancer
100%
Diseases
60%
Nuclear Magnetic Resonance Imaging
20%
Imaging
20%
Biological Marker
20%
Cancer Mortality
20%
Cancer Diagnosis
20%
Prostate Specific Antigen
20%
Biopsy Technique
20%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Diseases
60%
Biological Marker
20%
Cancer Mortality
20%
Prostate Specific Antigen
20%